Iradimed Co (IRMD) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $102.42
• Market Cap: $1.28B
• P/E Ratio: 57.43
• EPS: $1.75
• 52-Week High: $107.69
• 52-Week Low: $46.79

Market Sentiment

Iradimed Co currently has a Neutral sentiment score of 0.14.

About Iradimed Co

Iradimed Corporation is a leading developer and manufacturer of MRI-compatible medical devices, strategically headquartered in Winter Springs, Florida. With a focus on innovative solutions that significantly improve patient care during magnetic resonance imaging, the company serves both domestic and international markets. Iradimed's dedication to advancing medical technology and its specialized product offerings position it as a compelling investment opportunity for institutional investors lo...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Iradimed Co and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IRMD pay dividends?

Iradimed Co (IRMD) does not currently pay a regular dividend.

What is IRMD's P/E ratio?

Iradimed Co has a price-to-earnings (P/E) ratio of 57.43.

What is IRMD's market cap?

Iradimed Co (IRMD) has a market capitalization of $1.28B with a current stock price of $102.42.